RMD Q1 2026 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q1 2026 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.3B+9.1% YoY

Gross Profit

$821M61.5% margin

Operating Income

$447M33.4% margin

Net Income

$349M26.1% margin

EPS (Diluted)

$2.37

QoQ Revenue Growth

-0.9%

Cash Flow

Operating Cash Flow

$457M

Free Cash Flow

$414M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$8.3B

Total Liabilities

$2.2B

Stockholders' Equity

$6.1B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.2B	+9.1%
Gross Profit	$821M	$717M	+14.4%
Operating Income	$447M	$387M	+15.3%
Net Income	$349M	$311M	+11.9%

Revenue Segments

Sleep And Respiratory

$1.2B88%

Residential Care Software

$166M12%

Geographic Segments

Us Canada And Latin America

$775M58%

Combined Europe Asia And Other Markets

$395M30%

Global

$166M12%